Sign in
Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
Jeffrey S. Heier, MD
Annual Meeting Talks
2019
Episode 10: Cytokines Levels and Response to Ranibizumab in DME with Dr. Rajeev Muni
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Episode 15: Serum VEGF Levels in the IVAN Trial with Dr. Usha Chakravarthy
Category: Complications of Anterior Segment Surgery